Axoglatiran® FS: Generic of Copaxone® Preparation Based on Glatiramer Acetate
- Авторы: Skornyakov Y.1, Deryabin A.2, Skornyakova O.3
-
Учреждения:
- Nordic Chemical Co., Ministry of Health of Russia
- Perm Chemical Co.
- M. V. Lomonosov Moscow State University
- Выпуск: Том 51, № 4 (2017)
- Страницы: 301-306
- Раздел: Drugs
- URL: https://journals.rcsi.science/0091-150X/article/view/244582
- DOI: https://doi.org/10.1007/s11094-017-1603-6
- ID: 244582
Цитировать
Аннотация
General information about the synthesis and properties of glatiramer acetate (GA) drug substance and the principles and methods for verifying the pharmaceutical identity of GA drug substance and Copaxone® and generic Axoglatiran® FS (INN) that are based on it was presented. Registration certificate No. LP-003572 dated Apr. 18, 2016, was issued by the RF for the first domestic GA-based generic drug Axoglatiran® FS.
Ключевые слова
Об авторах
Yu. Skornyakov
Nordic Chemical Co., Ministry of Health of Russia
Автор, ответственный за переписку.
Email: skorn506@mail.ru
Россия, Moscow, 123001
A. Deryabin
Perm Chemical Co.
Email: skorn506@mail.ru
Россия, Perm, 614034
O. Skornyakova
M. V. Lomonosov Moscow State University
Email: skorn506@mail.ru
Россия, Moscow, 119991